CON
Concentra Group Holdings Parent, Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Strong buy
+65/100
Last price
36.50
▲ 0.29 (0.80%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
36.56
Prev close
36.21
Day high
36.82
Day low
36.16
Volume
906.41K
Market cap
$4.64B
P/E (TTM)
23.48
52W range
18.55 – 36.83
Day trading desk
Gap from prior close
+0.97%
Prior close 36.21
VWAP
—
—
Relative volume
0.00×
Quiet session
Session range
0.16%
36.50 – 36.56
Position in range
0%
Near session low
ATR (14D)
0.96
2.62% of price
Prior day high
36.51
PDH
Prior day low
35.48
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Avg 912.48K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+3.00%
+1.1%
1M
+5.60%
+4.4%
3M
+15.70%
+11.2%
6M
+70.65%
+52.5%
YTD
+84.96%
+70.7%
1Y
+75.42%
+59.0%
3Y
—
-82.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on CON open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
12.30M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 3, 26 | ORTENZIO ROBERT A Director |
SELL | 130.00K | $4.14M | Indirect |
| Jul 1, 26 | ORTENZIO ROBERT A Director |
SELL | 130.00K | $3.96M | Indirect |
| Jun 1, 26 | ORTENZIO ROBERT A Director |
SELL | 130.00K | $3.25M | Indirect |
| May 8, 26 | ORTENZIO ROBERT A Director |
SELL | 130.00K | $3.25M | Indirect |
| Dec 17, 25 | NEWTON WILLIAM KEITH Chief Executive Officer |
STOCK | 89.08K | $0 | Direct |
| Nov 25, 25 | ORTENZIO ROBERT A Director |
STOCK | 100.00K | $0 | Direct |
| Nov 4, 25 | ORTENZIO ROBERT A Director |
STOCK | 7.75K | $0 | Direct |
| Nov 4, 25 | THOMAS DANIEL J Director |
STOCK | 7.75K | $0 | Direct |
| Nov 4, 25 | BONNER BRIGID A Director |
STOCK | 15.50K | $0 | Direct |
| Nov 4, 25 | PEGUS CHERYL Director |
STOCK | 7.75K | $0 | Direct |
| Nov 4, 25 | NELSON SU ZAN CPA Officer |
STOCK | 60.00K | $0 | Direct |
| Nov 4, 25 | GALLARA GIOVANNI Officer |
STOCK | 60.00K | $0 | Direct |
| Nov 4, 25 | ANDERSON JOHN R. Officer |
STOCK | 60.00K | $0 | Direct |
| Nov 4, 25 | KENDALL DANIELLE Officer |
STOCK | 40.00K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CONSER JONATHAN P. |
Officer | 120.00K | Stock Award(Grant) |
DELORIMIER JOHN A. |
Officer | 120.00K | Stock Award(Grant) |
DICANIO MATTHEW T. |
President | 360.00K | Stock Award(Grant) |
GALLARA GIOVANNI |
Officer | 120.00K | Stock Award(Grant) |
GILBERT GREG M. |
Officer | 120.00K | Stock Award(Grant) |
KOSUTH MICHAEL A. |
Officer | 120.00K | Stock Award(Grant) |
NELSON SU ZAN CPA |
Officer | 120.00K | Stock Award(Grant) |
NEWTON WILLIAM KEITH |
Chief Executive Officer | 482.83K | Stock Gift |
ORTENZIO ROBERT A |
Director | — | Sale |
RYAN TIMOTHY F |
Officer | 120.00K | Stock Award(Grant) |
Fundamentals
Market cap$4.64B
Enterprise value$6.66B
Revenue (TTM)$2.29B
Gross profit$670.56M
EBITDA$461.61M
Net income$195.03M
EPS (TTM)$1.55
Free cash flow$204.79M
Total cash$158.04M
Total debt$2.14B
Book value / share$3.74
Shares outstanding127.52M
Float115.27M
Short % of float4.49%
Dividend yield0.69%
Beta (5Y)0.63
Valuation & profitability ratios
Trailing P/E23.48
Forward P/E19.77
PEG ratio—
Price / sales—
Price / book9.73
EV / revenue2.91
EV / EBITDA14.42
Gross margin29.31%
Operating margin19.29%
Profit margin8.69%
Return on equity47.06%
Return on assets8.16%
Debt / equity423.33
Current ratio1.38
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.16B | $1.90B | $1.84B | $1.72B | +13.9% |
| Operating revenue | $2.12B | $1.86B | $1.80B | $1.69B | +14.0% |
| Cost of revenue | $1.55B | $1.37B | $1.33B | $1.24B | +13.0% |
| Gross profit | $613.09M | $527.98M | $512.43M | $481.86M | +16.1% |
| Selling, general & admin | $203.31M | $156.32M | $152.00M | $149.98M | +30.1% |
| Total operating expense | $279.10M | $223.21M | $224.80M | $223.33M | +25.0% |
| Operating income | $333.99M | $304.76M | $287.63M | $258.53M | +9.6% |
| Net interest income | -$109.29M | -$69.69M | -$44.47M | -$31.64M | -56.8% |
| Pre-tax income | $223.83M | $231.39M | $242.63M | $224.90M | -3.3% |
| Tax provision | $50.98M | $59.50M | $57.89M | $52.65M | -14.3% |
| Net income | $166.41M | $166.54M | $179.95M | $166.73M | -0.1% |
| Net income to common | $166.41M | $166.54M | $179.95M | $166.73M | -0.1% |
| Basic EPS | 1.30 | 1.46 | 1.42 | 1.32 | -11.0% |
| Diluted EPS | 1.30 | 1.46 | 1.42 | 1.32 | -11.0% |
| EBIT | $333.12M | $301.09M | $287.10M | $256.54M | +10.6% |
| EBITDA | $408.93M | $368.26M | $360.15M | $330.20M | +11.0% |
| Basic shares | 128.30M | 114.20M | 126.59M | 126.59M | +12.3% |
| Diluted shares | 128.30M | 114.20M | 126.59M | 126.59M | +12.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $79.90M | $183.25M | $31.37M | $37.66M | -56.4% |
| Cash & short-term investments | $79.90M | $183.25M | $31.37M | $37.66M | -56.4% |
| Accounts receivable | $257.90M | $217.72M | $216.19M | $206.26M | +18.5% |
| Total current assets | $383.10M | $437.21M | $294.42M | $284.63M | -12.4% |
| Property, plant & equipment | $708.96M | $633.52M | $576.22M | $533.93M | +11.9% |
| Goodwill & intangibles | $1.72B | $1.44B | $1.45B | $1.47B | +19.6% |
| Total assets | $2.86B | $2.52B | $2.33B | $2.30B | +13.4% |
| Total current liabilities | $337.25M | $307.19M | $274.63M | $279.63M | +9.8% |
| Current debt | $10.74M | $10.09M | $1.46M | $1.67M | +6.4% |
| Long-term debt | $1.56B | $1.47B | $473.29M | $633.91M | +6.4% |
| Total debt | $2.10B | $1.95B | $905.00M | $1.04B | +7.8% |
| Total liabilities | $2.44B | $2.22B | $1.16B | $1.30B | +9.7% |
| Retained earnings | $146.45M | $13.55M | $685.29M | $508.59M | +980.6% |
| Shareholder equity | $393.28M | $275.67M | $0 | $0 | +42.7% |
| Working capital | $45.85M | $130.02M | $19.78M | $5.00M | -64.7% |
| Net tangible assets | -$1.33B | -$1.16B | -$1.45B | -$1.47B | -14.2% |
| Shares issued | 128.63M | 128.13M | 126.59M | 126.59M | +0.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $172.85M | $171.90M | $184.74M | $172.24M | +0.6% |
| Depreciation & amortisation | $75.82M | $67.18M | $73.05M | $73.67M | +12.9% |
| Stock-based compensation | $10.49M | $2.33M | $651.00K | $2.14M | +350.8% |
| Change in working capital | $7.96M | $30.18M | -$18.70M | $33.92M | -73.6% |
| Operating cash flow | $279.40M | $274.68M | $234.32M | $274.34M | +1.7% |
| Capital expenditure | -$82.33M | -$64.33M | -$69.34M | -$45.98M | -28.0% |
| Investing cash flow | -$414.86M | -$71.27M | -$75.31M | -$57.75M | -482.1% |
| Share buybacks | -$22.42M | -$15.40M | -$5.32M | -$29.05M | -45.6% |
| Dividends paid | -$32.08M | -$1.54B | $0 | $0 | +97.9% |
| Financing cash flow | $32.10M | -$51.53M | -$165.29M | -$209.86M | +162.3% |
| Free cash flow | $197.06M | $210.35M | $164.98M | $228.35M | -6.3% |
| End cash position | $79.90M | $183.25M | $31.37M | $37.66M | -56.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $606.03M | $569.55M | $539.08M | $572.80M | $550.78M | +6.4% |
| Operating revenue | $592.35M | $557.10M | $526.79M | $560.93M | $538.71M | +6.3% |
| Cost of revenue | $413.93M | $399.09M | $398.35M | $405.54M | $389.33M | +3.7% |
| Gross profit | $192.10M | $170.47M | $140.73M | $167.26M | $161.45M | +12.7% |
| Selling, general & admin | $56.68M | $55.28M | $50.78M | $52.88M | $52.93M | +2.5% |
| Total operating expense | $77.03M | $74.86M | $71.07M | $72.79M | $71.91M | +2.9% |
| Operating income | $115.07M | $95.61M | $69.66M | $94.47M | $89.54M | +20.4% |
| Net interest income | -$25.72M | -$26.00M | -$26.87M | -$28.68M | -$28.19M | +1.1% |
| Pre-tax income | $89.34M | $69.61M | $42.79M | $65.79M | $61.35M | +28.4% |
| Tax provision | $22.05M | $17.32M | $6.60M | $15.97M | $15.15M | +27.3% |
| Net income | $65.30M | $50.49M | $34.69M | $48.26M | $44.56M | +29.3% |
| Net income to common | $63.93M | $49.42M | $36.24M | $47.69M | $44.03M | +29.3% |
| Basic EPS | 0.51 | 0.39 | 0.27 | 0.38 | 0.35 | +30.8% |
| Diluted EPS | 0.51 | 0.39 | 0.27 | 0.38 | 0.35 | +30.8% |
| EBIT | $115.07M | $95.61M | $69.66M | $94.47M | $89.54M | +20.4% |
| EBITDA | $134.97M | $115.26M | $89.95M | $114.38M | $108.54M | +17.1% |
| Basic shares | 125.35M | 125.78M | 128.69M | 128.17M | 125.80M | -0.3% |
| Diluted shares | 127.79M | 125.78M | 128.69M | 128.17M | 128.17M | +1.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $158.04M | $61.70M | $79.90M | $49.94M | $73.87M | +156.1% |
| Cash & short-term investments | $158.04M | $61.70M | $79.90M | $49.94M | $73.87M | +156.1% |
| Accounts receivable | $299.82M | $296.51M | $257.90M | $278.97M | $271.75M | +1.1% |
| Total current assets | $506.48M | $404.21M | $383.10M | $375.44M | $395.17M | +25.3% |
| Property, plant & equipment | $748.46M | $724.54M | $708.96M | $711.45M | $693.61M | +3.3% |
| Goodwill & intangibles | $1.71B | $1.72B | $1.72B | $1.73B | $1.74B | -0.4% |
| Total assets | $3.01B | $2.89B | $2.86B | $2.84B | $2.84B | +4.2% |
| Total current liabilities | $367.94M | $320.88M | $337.25M | $312.65M | $335.07M | +14.7% |
| Current debt | $12.41M | $13.66M | $10.74M | $11.92M | $13.92M | -9.2% |
| Long-term debt | $1.56B | $1.56B | $1.56B | $1.60B | $1.65B | -0.1% |
| Total debt | $2.14B | $2.12B | $2.10B | $2.14B | $2.18B | +1.0% |
| Total liabilities | $2.50B | $2.44B | $2.44B | $2.43B | $2.47B | +2.8% |
| Retained earnings | $244.15M | $186.84M | $146.45M | $120.08M | $79.83M | +30.7% |
| Shareholder equity | $477.10M | $424.71M | $393.28M | $385.49M | $342.64M | +12.3% |
| Working capital | $138.54M | $83.34M | $45.85M | $62.79M | $60.10M | +66.2% |
| Net tangible assets | -$1.24B | -$1.29B | -$1.33B | -$1.35B | -$1.40B | +4.5% |
| Shares issued | 127.52M | 127.96M | 128.63M | 128.17M | 128.17M | -0.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $67.30M | $52.29M | $36.19M | $49.82M | $46.19M | — | +28.7% |
| Depreciation & amortisation | $19.90M | $19.65M | $20.29M | $19.91M | $19.00M | — | +1.3% |
| Stock-based compensation | $4.13M | $4.13M | $3.61M | $2.33M | $2.29M | — | -0.1% |
| Change in working capital | $44.67M | -$56.91M | $58.90M | -$23.09M | $19.99M | — | +178.5% |
| Operating cash flow | $135.21M | $21.02M | $118.69M | $60.63M | $88.38M | — | +543.3% |
| Capital expenditure | -$15.66M | -$11.09M | -$20.17M | -$21.21M | -$25.23M | — | -41.3% |
| Investing cash flow | -$14.20M | -$14.85M | -$20.13M | -$20.47M | -$79.51M | — | +4.4% |
| Share buybacks | -$10.96M | -$15.00M | — | — | $0 | $0 | +26.9% |
| Dividends paid | -$7.99M | -$8.02M | -$8.04M | -$8.01M | -$16.02M | — | +0.3% |
| Financing cash flow | -$24.67M | -$24.37M | -$68.60M | -$64.09M | $12.89M | — | -1.2% |
| Free cash flow | $119.55M | $9.93M | $98.52M | $39.42M | $63.15M | — | +1,103.8% |
| End cash position | $158.04M | $61.70M | $79.90M | $49.94M | $73.87M | — | +156.1% |
Options analytics
Put / call volume
0.22
Call-heavy session
Put / call open interest
0.22
Positioning, not flow
Max pain
35.00
-3.8% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
-6.2%
Calls bid over puts
Call volume
9
Contracts, this expiry
Put volume
2
Contracts, this expiry
Heaviest call OI
35.00
19 contracts
Heaviest put OI
35.00
8 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.42 | 0.52 | +23.5% |
| Mar 2026 | 0.34 | 0.40 | +18.2% |
| Dec 2025 | 0.28 | 0.28 | 0.0% |
| Sep 2025 | 0.38 | 0.39 | +2.2% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.44 | 8 | $605.03M | +5.6% |
| Next quarter | 0.29 | 8 | $571.03M | +5.9% |
| Current year | 1.65 | 9 | $2.35B | +8.7% |
| Next year | 1.84 | 9 | $2.49B | +6.0% |
Analyst targets & ownership
Mean target$41.00
High target$43.00
Low target$40.00
Implied upside12.33%
Analyst count8
ConsensusNONE
Strong buy / Buy2 / 7
Hold0
Sell / Strong sell0 / 0
Held by insiders9.65%
Held by institutions90.62%
Institutions holding405
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
35.28
+3.47% from price
SMA 20
35.23
+3.32% from price
SMA 50
34.32
+6.07% from price
SMA 100
31.42
+16.18% from price
SMA 200
26.79
+35.85% from price
EMA 12
35.43
+3.03% from price
EMA 26
35.00
+4.28% from price
EMA 50
34.01
+7.32% from price
RSI (14)
63.2
Neutral
MACD (12,26,9)
0.42
Hist 0.06
ATR (14)
0.96
2.63% of price
Realised vol 30D
21.2%
Annualised
Bollinger upper
36.52
20, 2σ
Bollinger lower
33.94
20, 2σ
50 / 200 cross
Golden
34.32 vs 26.79
Trend bias
Above 200
+35.85%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.39
Less volatile than market
Correlation to SPY
0.18
Largely independent
Realised vol 30D
21.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-13.6%
Peak to trough
Max drawdown 5Y
-23.5%
Peak to trough
ATR 14
0.96
2.63% of price
Beta (reported)
0.63
5Y monthly, from filing
Short interest
Shares short
3.18M
Prior 2.22M
Change vs prior
+43.5%
Shorts adding
% of float
4.49%
Normal
% of shares out
2.50%
Against total outstanding
Days to cover
4.5
Liquid
Float
115.27M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 10, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Aug 11, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Aug 10, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Aug 10, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jul 14, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Jul 1, 26 | William Blair | INITIATED | — | Outperform |
| Jun 5, 26 | Goldman Sachs | INITIATED | Buy | Buy |
| May 11, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Mar 5, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Feb 2, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Mar 19, 25 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Mar 12, 25 | Wells Fargo | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate$0.25 / yr
Forward yield0.69%
5-year avg yield—
Payout ratio16.13%
Ex-dividend dateAug 20, 2026
Next pay dateAug 28, 2026
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-08
Corporate Changes & Voting Matters
8-K · 2026-08-27
Periodic Financial Reports
10-Q · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-07-10
Periodic Financial Reports
10-Q · 2026-05-07
Corporate Changes & Voting Matters
8-K · 2026-04-30
Corporate Changes & Voting Matters
8-K · 2026-04-14
Annual Report to Shareholders
ARS · 2026-03-17
Headlines
Why Concentra’s Quiet Healthcare Business Keeps Winning
MarketBeat · 5d ago
CON or MEDP: Which Is the Better Value Stock Right Now?
Zacks · 9d ago
Is Anika Therapeutics (ANIK) Outperforming Other Medical Stocks This Year?
Zacks · 12d ago
Concentra Group Holdings Parent (CON) Beats Again And Expands In Florida, Is The Stock Still Undervalued?
Simply Wall St. · 20d ago
EQ's Concentra awards $150,000 to credit unions strengthening Canadian communities
PR Newswire · 22d ago
Concentra Group Holdings Parent, Inc. (CON) Hits Fresh High: Is There Still Room to Run?
Zacks · 22d ago
Concentra Expands Florida Footprint with New Daytona Beach Medical Center
Business Wire · 23d ago
CON vs. MEDP: Which Stock Is the Better Value Option?
Zacks · 26d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.